ClinicalTrialsFinder

Non-Muscle Invasive Bladder Urothelial Carcinoma Clinical Trials in Nashville, Tennessee

1 recruitingNashville, Tennessee

Showing 1–1 of 1 trials

Recruiting
Phase 1

A Phase 1, Open-label Trial of Belzupacap Sarotalocan (AU-011) in Bladder Cancer

Urothelial Carcinoma BladderNon Muscle Invasive Bladder CancerNMIBC+3 more
Aura Biosciences55 enrolled17 locationsNCT05483868